48,498
edits
Difference between revisions of "Polymorphous adenocarcinoma"
Jump to navigation
Jump to search
Polymorphous adenocarcinoma (view source)
Revision as of 20:14, 25 February 2021
, 20:14, 25 February 2021no edit summary
(→IHC) |
|||
| Line 9: | Line 9: | ||
| LMDDx = [[adenoid cystic carcinoma]], [[pleomorphic adenoma]], [[cribriform adenocarcinoma of the minor salivary gland]] | | LMDDx = [[adenoid cystic carcinoma]], [[pleomorphic adenoma]], [[cribriform adenocarcinoma of the minor salivary gland]] | ||
| Stains = | | Stains = | ||
| IHC = S-100 +ve, CK7 +ve, vimentin +ve | | IHC = S-100 +ve, CK7 +ve, vimentin +ve, p40 -ve, p63 +ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = | ||
| Line 31: | Line 31: | ||
'''Polymorphous adenocarcinoma''', abbreviated '''PAC''', is a rare malignant [[salivary gland]] tumour. | '''Polymorphous adenocarcinoma''', abbreviated '''PAC''', is a rare malignant [[salivary gland]] tumour. | ||
It was previously known as '''polymorphous low-grade adenocarcinoma''', abbreviated '''PLGA'''.<ref name=pmid29761209>{{cite journal | | It was previously known as '''polymorphous low-grade adenocarcinoma''', abbreviated '''PLGA'''.<ref name=pmid29761209>{{cite journal |authors=Vander Poorten V, Triantafyllou A, Skálová A, Stenman G, Bishop JA, Hauben E, Hunt JL, Hellquist H, Feys S, De Bree R, Mäkitie AA, Quer M, Strojan P, Guntinas-Lichius O, Rinaldo A, Ferlito A |title=Polymorphous adenocarcinoma of the salivary glands: reappraisal and update |journal=Eur Arch Otorhinolaryngol |volume=275 |issue=7 |pages=1681–1695 |date=July 2018 |pmid=29761209 |doi=10.1007/s00405-018-4985-5 |url=}}</ref> | ||
==General== | ==General== | ||